Karenitecin in Treating Patients With Recurrent Malignant Glioma

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

January 31, 2002

Conditions
Brain and Central Nervous System Tumors
Interventions
DRUG

karenitecin

Trial Locations (8)

21231

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore

30322

Winship Cancer Institute of Emory University, Atlanta

48202

Josephine Ford Cancer Center at Henry Ford Health System, Detroit

35294-3300

University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham

33612-9497

H. Lee Moffitt Cancer Center and Research Institute, Tampa

02114

Massachusetts General Hospital Cancer Center, Boston

27157-1030

Comprehensive Cancer Center at Wake Forest University, Winston-Salem

19104-4283

Abramson Cancer Center of the University of Pennsylvania, Philadelphia

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00014521 - Karenitecin in Treating Patients With Recurrent Malignant Glioma | Biotech Hunter | Biotech Hunter